Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Abstract: The promise of model-predictive control (MPC) in robotics has led to extensive development of efficient numerical optimal control solvers in line with differential dynamic programming ...
Chief Justice of India Surya Kant on Saturday said that the Supreme Court’s 1973 Kesavananda Bharati case verdict, which enunciated the basic structure doctrine, is “not… a mere legal precedent” but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback